glp-1/gip receptor agonists Schematic illustration of monoagonists, dual and triple Mechanisms of action of GLP-1

Supplier of assay kits, antibodies, biochemicals, and proteins and provider of contract research services

Glucagon-like peptide-1 (GLP-1) is a peptide hormone produced by enteroendocrine cells at low basal levels, but also by neurons in the caudal medulla [7]

Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes or type 2 diabetes: secondary analyses of pooled data from the SCALE Clinical Development Program [published correction appears in Diabetes Care 2018

Noureddin M, Khan S, Portell F, Jorkasky D, Dennis J, Khan O, et al

Notably, linagliptins ability to block this interaction in an in vitro system lacking GLP-1 suggests an M6P-mediated approach independent of GLP-1 (unpublished data)

Learn More Zepbound vials Available via LillyDirect Medication cost billed by LillyDirect A once-weekly injectable GLP-1/GIP dual agonist indicated for the treatment of overweight and obesity